OABINasdaqServices-Commercial Physical & Biological ResearchFiscal year ends December 31Also trades as OABIW
OmniAb, Inc.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 6, 2026
$4.69+0.10 (+2.18%)
Close on Oct 19, 2026
- Market cap
- $604.05M
- P/E (TTM)
- –
- Dividend yield
- –
Share price
+$3.03 (+182.5%)past year
Daily closes, adjusted for splits. Drag across the chart to measure a change.Earnings
OmniAb, Inc. grew revenue 67.0% to $38.46M over the twelve months to Jun 30, 2026. Free cash flow was -$18.14M.
Revenue
$38.46M
+67.0% vs. a year earlier
Operating income
-$48.37M
TTM Q2 2026
Free cash flow
-$18.14M
TTM Q2 2026
EPS, diluted
-$0.36
TTM Q2 2026
Key statistics
Valuation at the latest close; fundamentals over the trailing twelve months, balances at Jun 30, 2026
Valuation
- Market cap
- $604.05M
- P/E ratio
- –
- Price to sales
- 15.71
- Price to book
- 2.32
- Dividend yield
- –
- Free cash flow yield
- -3.00%
Fundamentals
- Revenue
- $38.46M
- Net income
- -$44.27M
- EPS, diluted
- -$0.36
- Free cash flow
- -$18.14M
- Book value per share
- $2.02
- Diluted shares
- 129M
Seven years at a glance
Fiscal years 2007 to 2025 and trailing twelve months, USD
Revenue
$38.46M+67.0% YoY
Operating income
-$48.37M
Net income
-$44.27M
EPS, diluted
-$0.36
Free cash flow
-$18.14M
Reported periodTrailing twelve months